Time-restricted eating without calorie counting was as effective as a calorie restriction diet for weight loss and cardiometabolic risk reduction in obese adults, according to findings published in Annals of Internal Medicine.
First-year medical students donned their white coats for the first time at Founders’ Day on August 4 at Fourth Presbyterian Church in Chicago.
Kai Holder, a fourth-year medical student, and Sydney Love Cush, a second-year medical student, have been named 2023-2024 Chicago Area Schweitzer Fellows.
Testing performance of rapid antigen tests for SARS-CoV-2 improved for both asymptomatic and symptomatic patients after testing multiple times in 48-hour intervals, according to findings published in the Annals of Internal Medicine.
Investigators led by Shana Kelley, PhD, have developed a novel approach for identifying sequences of artificial DNA with differing levels of binding to other small molecules, which could improve diagnostic monitoring for patients with chronic diseases.
Northwestern Medicine investigators have discovered a novel protein region that regulates DNA transcription elongation, suggesting a new therapeutic target for treating cancers and developmental disorders, according to findings published in Molecular Cell.
A single infusion of CAR T-cell therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, according to a recent clinical trial published in The Lancet.
Anali Cisneros, a first-year student in Feinberg’s Physician Assistant (PA) Program, is an Olympic-level athlete in race walking and recently competed at the Olympic trials for the Tokyo Summer Olympic games.
Northwestern Medicine investigators have discovered a novel mechanism that regulates neutrophil recruitment into tissue during inflammation, which could be targeted to treat different inflammatory diseases and conditions, according to a recent study published in the Journal of Clinical Investigation.
Adding a checkpoint inhibitor to conventional chemotherapy improved outcomes for patients with relapsed or refractory classic Hodgkin lymphoma, according to a Northwestern Medicine phase II clinical trial published in JAMA Oncology.